SyGest (Syntrion GmbH)
Welcome to the PulseAid listing for the SyGest drug offered from Syntrion GmbH. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Syntrion GmbH |
| NON-PROPRIETARY NAME: | CANDIDA PARAPSILOSIS and PENICILLIUM GLABRUM |
| SUBSTANCE NAME: | CANDIDA PARAPSILOSIS; PENICILLIUM GLABRUM |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2014-01-10 |
| END MARKETING DATE: | 2019-08-31 |
SyGest HUMAN OTC DRUG Details:
| Item Description | SyGest from Syntrion GmbH |
| LABELER NAME: | Syntrion GmbH |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 125; 125(mg/1; mg/1) |
| START MARKETING DATE: | 2014-01-10 |
| END MARKETING DATE: | 2019-08-31 |
| PRODUCT ID: | 10424-106_273c4e0b-eba4-46bc-959c-8d8bf0e57bc3 |
| PRODUCT NDC: | 10424-106 |
| APPLICATION NUMBER: | |
Other CANDIDA PARAPSILOSIS; PENICILLIUM GLABRUM Pharmaceutical Manufacturers / Labelers:
